News & Updates

NO TIME TO WAIT: SUSPECT & REFER EARLY IN ILD

Home-based end-of-life care beneficial for terminally ill non-cancer patients in SG

A home-based palliative care program for terminally ill patients with end-stage organ failure and severe frailty in Singapore has been shown to improve symptom control and honour the patients’ end-of-life preferences while reducing acute healthcare use and its associated costs.

OSA linked to thromboembolic event risk among women with PCOS

Women with polycystic ovarian syndrome (PCOS) may have an increased risk of thromboembolic events in the presence of obstructive sleep apnoea (OSA), according to a retrospective study.

Inhaled treprostinil confers benefit in idiopathic pulmonary fibrosis

Treatment with inhaled treprostinil helps preserve lung function and delay disease progression in patients with idiopathic pulmonary fibrosis (IPF), according to phase 3 data from the TETON-1 trial.

Novel dual PDE3/PDE4 inhibitor shows promise in COPD

In the treatment of patients with chronic obstructive pulmonary disease (COPD), the investigational dual phosphodiesterase (PDE) 3 and 4 inhibitor TQC3721 helps improve lung function, according to a phase 2 PACER-II study.

Adjuvant nivolumab confers no DFS benefit in resected NSCLC

In the treatment of patients with resected non–small cell lung cancer (NSCLC) without sensitizing EGFR and ALK alterations, adjuvant nivolumab does not appear to yield improvements in disease-free survival (DFS) when given after planned adjuvant chemotherapy and/or radiotherapy, according to a phase 3 study.